论文部分内容阅读
目的:研究在老年初诊2型糖尿病患者中使用门冬胰岛素30联合二甲双胍治疗的效果。方法:将我院收治的初诊2型糖尿病老年患者30例作为此次研究的研究对象,所有患者都使用门冬胰岛素30联合二甲双胍进行治疗,对比治疗前后患者的相关指标(空腹血糖、糖化血红蛋白以及体质量等)。结果:治疗后患者空腹血糖、糖化血红蛋白以及TG、LDL-C等指标较治疗前都有显著的改善,前后相比的差异经检验P<0.05,统计学意义明显。体质量等指标虽然也有相应的变化但是较治疗前差异不显著(P>0.05)。结论:在初诊2型糖尿病的老年患者中,使用门冬胰岛素30以及二甲双胍进行联合治疗,能够有效改善患者症状、降低其血糖并且不会出现严重的不良反应,具有一定的应用可行性。
OBJECTIVE: To study the effect of using aspart 30 combined with metformin in elderly patients with newly diagnosed type 2 diabetes. Methods: Thirty patients with newly diagnosed type 2 diabetes mellitus admitted to our hospital were enrolled in this study. All patients were treated with insulin aspart 30 combined with metformin. Compared with the patients before and after treatment (fasting blood glucose, glycosylated hemoglobin and Body weight, etc.). Results: After treatment, fasting blood glucose, glycosylated hemoglobin and TG, LDL-C and other indicators were significantly improved compared with before treatment, before and after comparison of the difference was tested P <0.05, statistically significant. Body weight and other indicators, although there are corresponding changes, but no significant difference compared with before treatment (P> 0.05). CONCLUSIONS: In the newly diagnosed type 2 diabetic elderly patients, the use of insulin aspart 30 and metformin combination therapy can effectively improve the symptoms of patients, reduce their blood sugar and does not appear serious adverse reactions, with a certain feasibility.